Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
The new facility offers an expanded laboratory alongside meeting areas dedicated to development meetings, formulation workshops, and brainstorming sessions
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
Biocon will acquire all of Viatris’ convertible preferred equity in Biocon Biologics for $400 million in cash and $415 million in newly issued Biocon shares
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
FDA's withholding of the PRV was contrary to law because no drug product containing phenobarbital sodium was 'previously approved'
At the heart of the showdown is a deep split among federal circuit courts over whether federal law overrides state failure-to-warn claims in Roundup personal-injury suits
Subscribe To Our Newsletter & Stay Updated
